DOCSLIB.ORG

MASARYK UNIVERSITY Molecular Interactions in Low-Grade Breast

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MASARYK UNIVERSITY Molecular Interactions in Low-Grade Breast MASARYK UNIVERSITY FACULTY OF SCIENCE Molecular interactions in low-grade breast cancer metastasis Ph.D. Dissertation JOSEF MARYÁŠ Supervisor: Doc. Mgr. Pavel Bouchal, Ph.D. DEPARTMENT OF BIOCHEMISTRY Brno 2020 Bibliografický záznam Autor: Mgr. Josef Maryáš Přírodovědecká fakulta, Masarykova univerzita Ústav Biochemie Název práce: Molekulární interakce v metastazování low-grade nádorů prsu Studijní program: Biochemie Specializace: Biochemie Vedoucí práce: Doc. Mgr. Pavel Bouchal, Ph.D. Akademický rok: 2019/2020 Počet stran: 108+109 Klíčová slova: PDLIM2, TRAF3IP2, RNF25, epiteliálně-mezenchymální tranzice, metastazování, karcinom prsu Bibliographic Entry Author: Mgr. Josef Maryáš Faculty of Science, Masaryk University Department of Biochemistry Title of Thesis: Molecular interactions in low-grade breast cancer metastasis Degree programme: Biochemistry Specialization: Biochemistry Supervisor: Doc. Mgr. Pavel Bouchal, Ph.D. Academic Year: 2019/2020 Number of Pages: 108+109 Keywords: PDLIM2, TRAF3IP2, RNF25, epithelial-mesenchymal transition, metastasis, breast carcinoma Abstrakt Nádory prsu (BrCa) představují heterogenní onemocnění, které je klasifikováno na základě histologických, klinických a/nebo imunohistochemických (IHC) markerů, které rovněž slouží jako prognostické a prediktivní faktory. Hlavní příčinou úmrtí pacientů s BrCa jsou však metastázy, které vznikají v procesu metastatické kaskády, multifaktoriálního a vícestupňového procesu zahrnujícího tzv. epiteliálně-mesenchymální tranzici (EMT). Je zřejmé, že metastatická kaskáda včetně EMT zahrnuje velké množství proteinů, na které lze cílit a modulovat tím proces vzniku metastáz. Disertační práce sumarizuje poznatky o proteinech PDZ and LIM domain protein 2 (PDLIM2), ring finger protein 25 (RNF25) a TRAF3 interacting protein 2 (TRAF3IP2), které byly identifikovány jako proteiny související s metastazováním do lymfatických uzlin u luminálních-A nádorů prsu pomocí kombinace proteomických a transkriptomických přístupů. Za účelem pochopení molekulární podstaty tohoto vztahu jsme se nejprve zaměřili na protein-proteinový interaktom a srovnali konvenční pull-down assay se surface plasmon resonance (SPR) čipy v kombinaci se “sequential window acquisition of all theoretical fragment ion spectra mass spectrometry” (SWATH-MS) pro identifikaci interakčních partnerů proteinu PDLIM2. Naše výsledky ukazují, že afinitní matrice a mechanismus promytí a eluce jsou kritickými kroky assaye, a ukazují SPR v kombinaci se SWATH-MS jako relevantní nástroj pro detekci protein-protein interakčních partnerů. Zadruhé, funkční potvrdily vztah proteinu PDLIM2 k EMT, hypoxii, proliferaci a adhezi nádorové buněčné linie MCF7, modelu odvozeném od luminálních-A nádorů prsu. Paralelní experimenty na imortalizovaných buňkách odvozených od normálního prsního epitelu MCF10A však odhalily jeho spíše tumor supresivní funkci, což vede k hypotéze o duální a na biologickém kontextu závislé roli PDLIM2 v procesu vzniku a vývoje nádorů prsu. Zatřetí, širokorozsahová celoproteomová analýza spojená s analýzou protein-proteinové interakční sítě, “gene set enrichment analysis” (GSEA) a analýzou migrace a invaze buněčné linie MCF7 prokázala souvislost zvýšených hladin proteinů PDLIM2, RNF25 a TRAF3IP2 s cytoskeletárními změnami, zvýšenou proliferací, migrací, invazí a s nádorovou progresí. Práce jako celek přispívá k pochopení molekulární sítě zapojené do metastazování luminálních-A nádorů prsu a jejího vlivu na fenotyp nádorových buněk. Abstract Breast cancer (BrCa) is a heterogeneous disease currently classified based on histological, clinical and/or immunohistochemical (IHC) markers that also serve as prognostic and predictive factors. However, the most common cause of death of BrCa patients are metastases, which are formed during metastatic cascade, the multistep and multifactorial process involving epithelial-to-mesenchymal transition (EMT). It is evident that metastatic cascade and EMT itself involve a large number of potentially targetable proteins that might modulate the process of metastasis formation. The dissertation thesis focuses on PDZ and LIM domain protein 2 (PDLIM2), ring finger protein 25 (RNF25) and TRAF3 interacting protein 2 (TRAF3IP2) which have been previously identified as proteins related to lymph node metastasis in luminal-A breast tumors using a combination of proteomic and transcriptomic approaches. To understand the molecular basis of this phenomenon, we first focused on protein-protein interactome and compared conventional pull-down assays on streptavidin agarose beads with surface plasmon resonance chips (SPR) in combination with sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) to identify PDLIM2 interactors. Our results show that solid support and mechanics of wash and elution are the critical aspects of the assay, and highlight SPR with SWATH-MS as a relevant tool for the detection of PDLIM2 protein-protein interactions. Second, a series of hypothesis-driven functional experiments confirmed association of PDLIM2 with EMT, hypoxia, proliferation and adhesion of MCF7 breast cancer cell line, a model of luminal-A breast cancer. However, the parallel experiments in immortalized normal epithelial breast cells MCF10A revealed its rather tumor suppressive role, leading to the hypothesis on dual and context dependent role in breast cancer development. Third, large- scale total proteome analysis together with the analysis of protein-protein interaction network, gene set enrichment analysis (GSEA) and functional analysis of migration and invasion of MCF7 breast cancer cell line demonstrated the association of elevated PDLIM2, RNF25 and TRAF3IP2 protein levels with cytoskeletal changes, increased proliferation, migration, invasion, and tumor progression. The work contributes to understanding the molecular network involved in luminal-A breast cancer metastasis and its impact on cancer cell phenotype. Acknowledgements I would like to thank my thesis supervisor, Pavel Bouchal for his time, guidance and continuous support. I would like to express my gratitude to him for providing suggestions and commentaries at every step during my PhD studies, while also giving me the freedom to design my own experiments and realize my own ideas. My work could not have been possible without the help and support of former members of Regional Centre for Applied Molecular Oncology. Especially, I would like to thank Monika D. and Iva P., for all discussions we had. I am also thankful to Jakub F., for his valuable technical support with MS experiments. My endless thanks belong to my family and friends. They always stand on my side, helped me, supported me and inspired me every day. Without them I would not become the person that I am today. Pledge I hereby declare that I have worked on this thesis independently, using primary and secondary sources listed in the bibliography, under the supervision of Dr. Pavel Bouchal. In Brno ........................ Josef Maryáš List of selected original publications with dissertant’s contributions The dissertation thesis is based on one peer-reviewed review paper (Review paper 1), two original peer-reviewed papers in journals with impact factor (Research papers 1 - 2), one manuscript in peer-review process published on preprint server (Research paper 3) and one manuscript in preparation (Research paper 4). The dissertant‟s contribution to each paper is described in commentaries below. Publications are listed in Appendices 1 to 5. Review paper 1 (Appendix1): Maryas J, Faktor J, Dvorakova M, Struharova I, Grell P, Bouchal P. Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges. Proteomics. 2014;14(4-5):426-40. (IF2014 = 3.807, Q1 in Biochemical Research Methods, Q1 in Biochemistry and Molecular Biology). https://onlinelibrary.wiley.com/doi/epdf/10.1002/pmic.201300264 Estimated personal contribution: 30 % JM contributed to this work by summarizing the biological basis of cancer metastasis and functional proteomics studies in pro-metastatic mechanisms. Research paper 1 (Appendix 2): Bouchal P, Dvorakova M, Roumeliotis T, Bortlicek Z, Ihnatova I, Prochazkova I, Ho J.T.C, Maryas J, Imrichova H, Budinska E, et al. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF- κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer. Mol. Cell. Proteomics MCP. 2015;14:1814-30. (IF2015 = 5.912, Q1/92.857 percentile in Biochemical Research Methods). https://www.mcponline.org/content/mcprot/14/7/1814.full.pdf Estimated personal contribution: 10 % JM‟s contribution to this work consisted of antibodies specificity validation and dilutions optimization using western blot, and preparation of materials for publication. Research paper 2 (Appendix 3): Maryas J, Faktor J, Skladal P, Bouchal P. Pull-down assay on streptavidin beads and surface plasmon resonance chips for SWATH mass spectrometry based interactomics. Cancer Genomics and Proteomics. 2018;15(5):395-404. (IF2018 = 3.147, Q2 in Oncology, Q2 in Genetics and Heredity). http://cgp.iiarjournals.org/content/15/5/395.full.pdf+html Estimated personal contribution: 70 % JM designed and performed majority of experiments (cell cultivation, transfection, cell lysis and sample preparation for Methods 1-4 and pull-down for Methods 1-3), analyzed potential interactors and drafted the manuscript. Research paper 3 (Appendix 4): Maryas J, Pribyl J, Bouchalova P, Skladal P, Bouchal
Load more

Recommended publications
  • Sexual Dimorphism in Brain Transcriptomes of Amami Spiny Rats (Tokudaia Osimensis): a Rodent Species Where Males Lack the Y Chromosome Madison T
    Ortega et al. BMC Genomics (2019) 20:87 https://doi.org/10.1186/s12864-019-5426-6 RESEARCHARTICLE Open Access Sexual dimorphism in brain transcriptomes of Amami spiny rats (Tokudaia osimensis): a rodent species where males lack the Y chromosome Madison T. Ortega1,2, Nathan J. Bivens3, Takamichi Jogahara4, Asato Kuroiwa5, Scott A. Givan1,6,7,8 and Cheryl S. Rosenfeld1,2,8,9* Abstract Background: Brain sexual differentiation is sculpted by precise coordination of steroid hormones during development. Programming of several brain regions in males depends upon aromatase conversion of testosterone to estrogen. However, it is not clear the direct contribution that Y chromosome associated genes, especially sex- determining region Y (Sry), might exert on brain sexual differentiation in therian mammals. Two species of spiny rats: Amami spiny rat (Tokudaia osimensis) and Tokunoshima spiny rat (T. tokunoshimensis) lack a Y chromosome/Sry, and these individuals possess an XO chromosome system in both sexes. Both Tokudaia species are highly endangered. To assess the neural transcriptome profile in male and female Amami spiny rats, RNA was isolated from brain samples of adult male and female spiny rats that had died accidentally and used for RNAseq analyses. Results: RNAseq analyses confirmed that several genes and individual transcripts were differentially expressed between males and females. In males, seminal vesicle secretory protein 5 (Svs5) and cytochrome P450 1B1 (Cyp1b1) genes were significantly elevated compared to females, whereas serine (or cysteine) peptidase inhibitor, clade A, member 3 N (Serpina3n) was upregulated in females. Many individual transcripts elevated in males included those encoding for zinc finger proteins, e.g.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • A De Novo 2Q35-Q36.1 Deletion Incorporating IHH in a Chinese Boy (47,XYY) with Syndactyly, Type III Waardenburg Syndrome, and Congenital Heart Disease
    A de novo 2q35-q36.1 deletion incorporating IHH in a Chinese boy (47,XYY) with syndactyly, type III Waardenburg syndrome, and congenital heart disease D. Wang1,2*, G.F. Ren3*, H.Z. Zhang1, C.Y. Yi4 and Z.J. Peng3 1Medical Institute of Pediatrics, Qilu Children’s Hospital of Shandong University, Jinan, Shandong, China 2Institute of Cardiovascular Disease, General Hospital of Jinan Military Region, Jinan, Shandong, China 3Department of Pediatrics, Qilu Children’s Hospital of Shandong University, Jinan, Shandong, China 4Children’s Medical Laboratory Diagnosis Center, Qilu Children’s Hospital of Shandong University, Jinan, Shandong, China *These authors contributed equally to this study. Corresponding authors: C.Y. Yi / Z.J. Peng E-mail: [email protected] / [email protected] Genet. Mol. Res. 15 (4): gmr15049060 Received August 5, 2016 Accepted November 8, 2016 Published December 2, 2016 DOI http://dx.doi.org/10.4238/gmr15049060 Copyright © 2016 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution ShareAlike (CC BY-SA) 4.0 License. ABSTRACT. Reports of terminal and interstitial deletions of the long arm of chromosome 2 are rare in the literature. Here, we present a case report concerning a Chinese boy with a 47,XYY karyotype and a de novo deletion comprising approximately 5 Mb between 2q35 and q36.1, along with syndactyly, type III Waardenburg syndrome, and congenital heart disease. High-resolution chromosome analysis Genetics and Molecular Research 15 (4): gmr15049060 D. Wang et al. 2 to detect copy number variations was carried out using an Affymetrix microarray platform, and the genes affected by the patient’s deletion, including IHH, were determined.
    [Show full text]
  • Exome Sequencing of 457 Autism Families Recruited Online Provides Evidence for Autism Risk Genes
    www.nature.com/npjgenmed ARTICLE OPEN Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes Pamela Feliciano1, Xueya Zhou 2, Irina Astrovskaya 1, Tychele N. Turner 3, Tianyun Wang3, Leo Brueggeman4, Rebecca Barnard5, Alexander Hsieh 2, LeeAnne Green Snyder1, Donna M. Muzny6, Aniko Sabo6, The SPARK Consortium, Richard A. Gibbs6, Evan E. Eichler 3,7, Brian J. O’Roak 5, Jacob J. Michaelson 4, Natalia Volfovsky1, Yufeng Shen 2 and Wendy K. Chung1,8 Autism spectrum disorder (ASD) is a genetically heterogeneous condition, caused by a combination of rare de novo and inherited variants as well as common variants in at least several hundred genes. However, significantly larger sample sizes are needed to identify the complete set of genetic risk factors. We conducted a pilot study for SPARK (SPARKForAutism.org) of 457 families with ASD, all consented online. Whole exome sequencing (WES) and genotyping data were generated for each family using DNA from saliva. We identified variants in genes and loci that are clinically recognized causes or significant contributors to ASD in 10.4% of families without previous genetic findings. In addition, we identified variants that are possibly associated with ASD in an additional 3.4% of families. A meta-analysis using the TADA framework at a false discovery rate (FDR) of 0.1 provides statistical support for 26 ASD risk genes. While most of these genes are already known ASD risk genes, BRSK2 has the strongest statistical support and reaches genome-wide significance as a risk gene for ASD (p-value = 2.3e−06).
    [Show full text]
  • Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and B-Catenin– Independent Targets by Proteomics
    Published OnlineFirst June 3, 2019; DOI: 10.1158/1541-7786.MCR-18-1154 Cancer "-omics" Molecular Cancer Research Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and b-Catenin– Independent Targets by Proteomics Olesja Popow1,2,3,Joao~ A. Paulo2, Michael H. Tatham4, Melanie S. Volk3, Alejandro Rojas-Fernandez5, Nicolas Loyer3, Ian P. Newton3, Jens Januschke3, Kevin M. Haigis1,6, and Inke Nathke€ 3 Abstract Adenomatous Polyposis Coli (APC) is the most frequently tion between endogenous MINK1 and APC and further mutated gene in colorectal cancer. APC negatively regulates confirmed the negative, and b-catenin–independent, regu- the Wnt signaling pathway by promoting the degradation of lation of MINK1 by APC. Increased Mink1/Msn levels were b-catenin, but the extent to which APC exerts Wnt/b-cate- also observed in mouse intestinal tissue and Drosophila nin–independent tumor-suppressive activity is unclear. To follicular cells expressing mutant Apc/APC when compared identify interaction partners and b-catenin–independent with wild-type tissue/cells. Collectively, our results highlight targets of endogenous, full-length APC, we applied label- the extent and importance of Wnt-independent APC func- free and multiplexed tandem mass tag-based mass spec- tions in epithelial biology and disease. trometry. Affinity enrichment-mass spectrometry identified more than 150 previously unidentified APC interaction Implications: The tumor-suppressive function of APC, the partners. Moreover, our global proteomic analysis revealed most frequently mutated gene in colorectal cancer, is mainly that roughly half of the protein expression changes that attributed to its role in b-catenin/Wnt signaling. Our study occur in response to APC loss are independent of b-catenin.
    [Show full text]
  • Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology
    Behavior Genetics (2018) 48:198–208 https://doi.org/10.1007/s10519-018-9893-3 ORIGINAL RESEARCH Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology David Curtis1,2 · Leda Coelewij1 · Shou‑Hwa Liu1 · Jack Humphrey1,3 · Richard Mott1 Received: 22 November 2017 / Accepted: 13 March 2018 / Published online: 21 March 2018 © The Author(s) 2018 Abstract A previous study of exome-sequenced schizophrenia cases and controls reported an excess of singleton, gene-disruptive vari- ants among cases, concentrated in particular gene sets. The dataset included a number of subjects with a substantial Finnish contribution to ancestry. We have reanalysed the same dataset after removal of these subjects and we have also included non- singleton variants of all types using a weighted burden test which assigns higher weights to variants predicted to have a greater effect on protein function. We investigated the same 31 gene sets as previously and also 1454 GO gene sets. The reduced dataset consisted of 4225 cases and 5834 controls. No individual variants or genes were significantly enriched in cases but 13 out of the 31 gene sets were significant after Bonferroni correction and the “FMRP targets” set produced a signed log p value (SLP) of 7.1. The gene within this set with the highest SLP, equal to 3.4, was FYN, which codes for a tyrosine kinase which phosphorylates glutamate metabotropic receptors and ionotropic NMDA receptors, thus modulating their trafficking, subcellular distribution and function. In the most recent GWAS of schizophrenia it was identified as a “prioritized candidate gene”.
    [Show full text]
  • Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology
    Behavior Genetics https://doi.org/10.1007/s10519-018-9893-3 ORIGINAL RESEARCH Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology David Curtis1,2 · Leda Coelewij1 · Shou‑Hwa Liu1 · Jack Humphrey1,3 · Richard Mott1 Received: 22 November 2017 / Accepted: 13 March 2018 © The Author(s) 2018 Abstract A previous study of exome-sequenced schizophrenia cases and controls reported an excess of singleton, gene-disruptive vari- ants among cases, concentrated in particular gene sets. The dataset included a number of subjects with a substantial Finnish contribution to ancestry. We have reanalysed the same dataset after removal of these subjects and we have also included non- singleton variants of all types using a weighted burden test which assigns higher weights to variants predicted to have a greater effect on protein function. We investigated the same 31 gene sets as previously and also 1454 GO gene sets. The reduced dataset consisted of 4225 cases and 5834 controls. No individual variants or genes were significantly enriched in cases but 13 out of the 31 gene sets were significant after Bonferroni correction and the “FMRP targets” set produced a signed log p value (SLP) of 7.1. The gene within this set with the highest SLP, equal to 3.4, was FYN, which codes for a tyrosine kinase which phosphorylates glutamate metabotropic receptors and ionotropic NMDA receptors, thus modulating their trafficking, subcellular distribution and function. In the most recent GWAS of schizophrenia it was identified as a “prioritized candidate gene”. Two of the subunits of the NMDA receptor which are substrates of FYN are coded for by GRIN1 (SLP = 1.7) and GRIN2B (SLP = 2.1).
    [Show full text]
  • Identification of Novel Regulatory Genes in Acetaminophen
    IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN A THESIS IN Cell Biology and Biophysics and Bioinformatics Presented to the Faculty of the University of Missouri-Kansas City in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY By KATHERINE ANNE SHORTT B.S, Indiana University, Bloomington, 2011 M.S, University of Missouri, Kansas City, 2014 Kansas City, Missouri 2018 © 2018 Katherine Shortt All Rights Reserved IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN Katherine Anne Shortt, Candidate for the Doctor of Philosophy degree, University of Missouri-Kansas City, 2018 ABSTRACT Acetaminophen (APAP) is a commonly used analgesic responsible for over 56,000 overdose-related emergency room visits annually. A long asymptomatic period and limited treatment options result in a high rate of liver failure, generally resulting in either organ transplant or mortality. The underlying molecular mechanisms of injury are not well understood and effective therapy is limited. Identification of previously unknown genetic risk factors would provide new mechanistic insights and new therapeutic targets for APAP induced hepatocyte toxicity or liver injury. This study used a genome-wide CRISPR/Cas9 screen to evaluate genes that are protective against or cause susceptibility to APAP-induced liver injury. HuH7 human hepatocellular carcinoma cells containing CRISPR/Cas9 gene knockouts were treated with 15mM APAP for 30 minutes to 4 days. A gene expression profile was developed based on the 1) top screening hits, 2) overlap with gene expression data of APAP overdosed human patients, and 3) biological interpretation including assessment of known and suspected iii APAP-associated genes and their therapeutic potential, predicted affected biological pathways, and functionally validated candidate genes.
    [Show full text]
  • Whole-Exome Sequencing in Familial Parkinson Disease
    Supplementary Online Content Farlow JL, Robak LA, Hetrick K, et al. Whole-exome sequencing in familial Parkinson disease. JAMA Neurol. Published online November 23, 2015. doi:10.1001/jamaneurol.2015.3266. eMethods. Supplemental Methods eFigure 1. Pedigrees of Discovery Cohort Families A-I eFigure 2. Pedigrees of Discovery Cohort Families J-Q eFigure 3. Pedigrees of Discovery Cohort Families R-Z eFigure 4. Pedigrees of Discovery Cohort Families AA-AF eTable 1. Single-Nucleotide Variants Identified in the Filtered Genes With GO Annotation eTable 2. Primer Sequences for Sanger Sequencing Verification of Identified Variants of Interest This supplementary material has been provided by the authors to give readers additional information about their work. © 2015 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 eMethods. Supplemental Methods Whole exome sequencing Discovery cohort. All members of each family were sequenced at the same center (44 samples/15 families at the Center for Inherited Disease Research [CIDR], and 53 samples/18 families at the HudsonAlpha Institute for Biotechnology). One family with 4 members was sequenced at both centers (eMethods). The Agilent SureSelect 50Mb Human All Exon Kit (CIDR) and Nimblegen 44.1Mb SeqCap EZ Exome Capture version 2.0 (HudsonAlpha) were used for capture, and the Illumina HiSeq 2000 system was used for 100bp paired-end sequencing. Samples were aligned to the human genome (build hg19) using Burrows Wheeler Aligner1. The Genome Analysis Toolkit (GATK)2 was used for local realignment, base quality score recalibration, and multi-sample variant calling (Unified Genotyper) for the samples sequenced at CIDR and HudsonAlpha separately.
    [Show full text]
  • Computational Modelling of Human Transcriptional Regulation by an Information Theory-Based Approach
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 4-12-2018 2:00 PM Computational Modelling of Human Transcriptional Regulation by an Information Theory-based Approach Ruipeng Lu The University of Western Ontario Supervisor Rogan, Peter K. The University of Western Ontario Graduate Program in Computer Science A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Ruipeng Lu 2018 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Bioinformatics Commons, Biostatistics Commons, Computational Biology Commons, Congenital, Hereditary, and Neonatal Diseases and Abnormalities Commons, Genomics Commons, Microarrays Commons, Other Computer Sciences Commons, and the Statistical Methodology Commons Recommended Citation Lu, Ruipeng, "Computational Modelling of Human Transcriptional Regulation by an Information Theory- based Approach" (2018). Electronic Thesis and Dissertation Repository. 5305. https://ir.lib.uwo.ca/etd/5305 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract ChIP-seq experiments can identify the genome-wide binding site motifs of a transcription factor (TF) and determine its sequence specificity. Multiple algorithms were developed to derive TF binding site (TFBS) motifs from ChIP-seq data, including the entropy minimization-based Bipad that can derive both contiguous and bipartite motifs. Prior studies applying these algorithms to ChIP-seq data only analyzed a small number of top peaks with the highest signal strengths, biasing their resultant position weight matrices (PWMs) towards consensus-like, strong binding sites; nor did they derive bipartite motifs, disabling the accurate modelling of binding behavior of dimeric TFs.
    [Show full text]
  • How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal a Breast Cancer?
    cancers Article How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer? Petr Lapcik 1, Anna Pospisilova 1, Lucia Janacova 1, Peter Grell 2, Pavel Fabian 3 and Pavel Bouchal 1,* 1 Department of Biochemistry, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic; [email protected] (P.L.); [email protected] (A.P.); [email protected] (L.J.) 2 Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic; [email protected] 3 Department of Oncological Pathology, Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-54-9493251 Received: 30 June 2020; Accepted: 11 September 2020; Published: 16 September 2020 Simple Summary: Lymph node status is one of the best prognostic factors in breast cancer, however, its association with distant metastasis is not straightforward. Here we compare molecular mechanisms of nodal and distant metastasis in molecular subtypes of breast cancer, with major focus on luminal A patients. Our results indicate that lymph node positivity is associated with NF-κB and Src pathways and is related to high risk of distant metastasis in luminal A patients. Distant metastasis of lymph node negative tumors is related to cell proliferation control and thrombolysis, whereas distant metastasis of lymph node positive tumors is associated mostly to immune response. These mechanisms vary in other molecular subtypes. Our data indicate that the management of breast cancer and prevention of distant metastasis requires stratified approach based on targeted strategies. Abstract: Lymph node status is one of the best prognostic factors in breast cancer, however, its association with distant metastasis is not straightforward.
    [Show full text]
  • Mosaic Origin of the Eukaryotic Kinetochore
    Mosaic origin of the eukaryotic kinetochore Eelco C. Tromera,b,c,1,2, Jolien J. E. van Hooffa,b,1, Geert J. P. L. Kopsb,d,3, and Berend Snela,2,3 aTheoretical Biology and Bioinformatics, Biology, Science Faculty, Utrecht University, 3584 CH Utrecht, The Netherlands; bOncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, 3584 CT Utrecht, The Netherlands; cDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom; and dUniversity Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands Edited by W. Ford Doolittle, Dalhousie University, Halifax, NS, Canada, and approved April 30, 2019 (received for review December 24, 2018) The emergence of eukaryotes from ancient prokaryotic lineages In this study, we addressed the question of how the kineto- embodied a remarkable increase in cellular complexity. While pro- chore originated. Leveraging the power of detailed phylogenetic karyotes operate simple systems to connect DNA to the segregation analyses, improved sensitive sequence searches, and new struc- machinery during cell division, eukaryotes use a highly complex tural insights, we traced the evolutionary origins of the 52 pro- protein assembly known as the kinetochore. Although conceptually teins that we now assign to the LECA kinetochore. Based on our similar, prokaryotic segregation systems and the eukaryotic kineto- findings, we propose that the LECA kinetochore was of mosaic chore are not homologous. Here we investigate the origins of the origin; it contained proteins that shared ancestry with proteins kinetochore before the last eukaryotic common ancestor (LECA) using involved in various core eukaryotic processes, as well as potentially phylogenetic trees, sensitive profile-versus-profile homology detection, novel proteins.
    [Show full text]